Kevin Koch
InvestorVenture Partner at OrbiMed · Board director at Neurogastrx
Boulder, Colorado
Writes $1M – $75M checks · typically $4M
Find your path to Kevin
233 people in our graph share verified history with Kevin — schools, employers, funds. One of them is your warm intro.
Femi AdewumiunlockedKevin: together at University of Ibadan
×9Kevin: together at University of Surrey
Kevin: together at University of Ibadan
Kevin: together at OrbiMed
About
Kevin Koch is President and CEO of Edgewise Therapeutics, a public biotechnology company he founded. Over 12 years, the company developed 21 investigational new drugs across multiple therapeutic areas. Koch has experience in corporate strategy, investor relations, and business development within vertically integrated, research-driven organizations.
Board director at Neurogastrx
Intro paths
→
In turn, Kevin can intro founders to Neurogastrx's investors below.
Neurogastrx's investors · 8
5AM VenturesBoston · $100K – $4M checks · since 2021OrbiMedNew York · $1M – $75M checks · since 2021RTW Investments L.P.New York · since 2021Samsara BioCapitalPalo Alto · since 2021venBio Global StrategicSan Francisco · since 2021venBio PartnersSan FranciscoVivo CapitalPalo Alto · $10M – $50M checks · since 2021Westlake Village BioPartnersLos Angeles · $100K – $5M checks · since 2021
Co-founders at Neurogastrx
CD
Cyril De ColleFounder
Experience
- KONSTRUCTUM CONTRACTING COMPANYChairmancurrent2023 — presentLagos State, Nigeria
- CE-IV General PartnersManaging Partnercurrent2022 — present
- ENYO RETAIL & SUPPLYFounder2017 — 2021Nigeria
- Oando Marketing PlcCEO2011 — 2016Nigeria
- Oando PlcChief Operating Officer2009 — 2011
- Oando PlcHead Of Investor Relations2008 — 2009London, England, United Kingdom
- Oando PlcInformation Technology Manager2005 — 2007Nigeria
Skills & more
Microsoft Excel4Business Expansion6Portfolio Management5Product Development3Stakeholder Management5Organizational Development4Investor Relations5Energy Industry5Information Technology5Project Management4Operations Management79Energy99
+10 more
ProcurementOil/GasSupply Chain ManagementChange ManagementLogisticsStrategic SourcingSupply ChainContract NegotiationBusiness StrategyPeople ManagementFrom Kevin's professional profile.
Investments
Board seats
Per SEC Form D filings.
Colleagues at OrbiMed
Aldo Brambilla
Associate at Silver Lake Partners
Alexander M. Cooper
Investor at OrbiMed
Anat Naschitz
Executive Officer at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Ava Poole
Investor at Insight Partners
Frequently asked questions
- Who is Kevin Koch?
- Kevin Koch is President and CEO of Edgewise Therapeutics, a public biotechnology company he founded. Over 12 years, the company developed 21 investigational new drugs across multiple therapeutic areas. Koch has experience in corporate strategy, investor relations, and business development within vertically integrated, research-driven organizations.
- Where does Kevin Koch work?
- Kevin Koch is Venture Partner at OrbiMed and Board director at Neurogastrx.
- What check size does Kevin Koch write?
- Kevin Koch typically writes checks of $1M – $75M.
- What boards does Kevin Koch sit on?
- Kevin Koch holds tracked board seats at Neurogastrx.
- Where did Kevin Koch go to school?
- Kevin Koch studied at University of Surrey (Master of Science - MS, International Business); University of Ibadan (Bsc, Applied Mathematics).
Same school
Also attended University of Surrey63
AndreaIR at NAPNathaniel DahanInvestor at SynconaWilliam DutsonInvestor at SynconaNicola GreenwayChief Human Resources Officer at Takeda VenturesKieran MudryyPartner at 4BIO CapitalAlex ChalikiopoulosHead of Absolute Return & Credit at RIT Capital Partners
+ 57 more
Also attended University of Ibadan19
Femi AdewumiMESTx Operations Director at Meltwater Entrepreneurial School of Technology (MEST)Moyosoreoluwa OgunkoyaAdministrative Executive at Ventures PlatformAbiola OlatoyeAssociate at Michigan Capital NetworkBanji FehintolaExecutive Director and Head of Financial Services at Africa Finance CorporationOlufunto OludeSCIDaR at i3 — Investing in Innovation AfricaTobiloba FadesereBusiness Development Adviser: Micro-entrepreneur at Shell Foundation
+ 13 more
